Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Valeant Pharma To Acquire Certain Assets From Atlantis Pharma - Quick Facts

RELATED NEWS
Trade VRX now with 

Valeant Pharmaceuticals International Inc. (VRX: Quote,VRX.TO: Quote) announced that it has signed an agreement to acquire certain assets from Atlantis Pharma, a branded generics pharmaceutical company located in Mexico with a broad product portfolio, including products in the gastro, analgesics and anti-inflammatory therapeutic categories, for approximately $71 million.

The acquired assets' total revenue in 2011 was approximately $26 million and is expected to deliver double digit growth in 2012. The transaction is expected to close in the second quarter, subject to certain closing conditions including regulatory approvals, and is expected to be immediately accretive.

Click here to receive FREE breaking news email alerts for Valeant Pharmaceuticals International and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
British economic growth remained high as expected in the second quarter as a robust expansion in the dominant service sector, and industry completely offset the slight weakness in the construction sector. With the second quarter expansion, GDP returned to its pre-crisis level. Gross domestic product grew 0.8 percent sequentially in the second quarter, the same rate as seen in the first quarter. 2.2 billion people in the world are poor or near-poor, according to the United Nations 2014 Human Development Report. Entitled Sustaining "Human Progress: Reducing Vulnerabilities and Building Resilience", the report was launched in Tokyo on Thursday by Japanese Prime Minister Shinzo Abe, United Nations... German business confidence eased for the third successive month to its lowest level since October, amid rising concerns over the impact of the worsening conflicts in Ukraine and the Middle East on the largest Eurozone economy. The Business Climate Index for industry and trade fell to 108.0 points in July from 109.7 in June, the results of a survey by the Munich-based Ifo Institute showed Friday.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.